Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
GANX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +26.2%
GANX
Gain Therapeutics, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
gain
therapeutics
nasdaq
price
last
2024
common
disease
02287
parkinson
trading
development
2023
rating
high
offering
small
bethesda
globe
newswire
StonvexStonvexStonvexStonvex